FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Issues Early Alert on Erbe Flexible Cryoprobes

FDA issues an early alert regarding a potential safety issue with certain Erbe USA Flexible Cryoprobes, following reports that some devices may ruptur...

latest-news-card-1
Marketing

Hims & Hers Super Bowl Ad Hit

The Institute for Safe Medicines calls on FDA, the Federal Trade Commission, and the Department of Justice to take enforcement action against Hims & H...

latest-news-card-1
Marketing

FDA DTC Ad Crackdown Raises Legal Issues: Attorneys

Five Sidley attorneys recommend ways in which drug companies can analyze their direct-to-consumer promotions to see if they are likely to run afoul of...

latest-news-card-1
Biologics

Updated Guidance Clarifies Biosimilar Development Requirements

FDA posts an updated draft guidance outlining new and revised recommendations for companies developing biosimilar products.

latest-news-card-1
Biologics

Incyte Gets Complete Response Over Catalent Inspection Issues

FDA sends Incyte a complete response letter for its supplemental BLA for Zynyz (retifanlimab-dlwr) injection that cited inspection findings (not spec...

latest-news-card-1
Human Drugs

Group urges Pfizer to Retract Threat on Drug Supplies

Consumer advocacy group Public Citizen urges Pfizer to commit to maintaining access to its medicines in Europe after comments by CEO Albert Bourla sug...

latest-news-card-1
Human Drugs

Roche Breast Cancer Drug Misses Endpoint in Late-Stage Trial

Roche reports that its investigational breast cancer drug giredestrant failed to significantly extend progression-free survival in a Phase 3 study whe...

latest-news-card-1
Human Drugs

FDA Meets with States to Advance Canada Importation Plan

FDA says it recently held a meeting with several states to discuss implementation of a program that would allow the importation of certain lower-cost ...

latest-news-card-1
Human Drugs

Xenon Reports Positive Phase 3 Data for Epilepsy Drug

Xenon Pharmaceuticals says its experimental epilepsy drug azetukalner met the primary endpoint in a late-stage clinical trial in patients with focal o...

latest-news-card-1
Human Drugs

Ipsen Withdraws Tazverik Over Safety Data

Ipsen voluntarily withdraws Tazverik (tazemetostat) from the market based on emerging data from the ongoing Phase 1b/3 SYMPHONY-1 trial due to safety ...